fashion -WSS

fashion

author：focus 2025-09-06 03:54:29 - browse：95345

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

'Null' research findings aren't empty of meaning. Let's publish them

Sen. Bill Cassidy on how to lower drug prices

Drinking water from half of US faucets contains PFAS: Study

Medicare slashes safety net hospital payments by nearly $1 billion

'Null' research findings aren't empty of meaning. Let's publish them

Neutralizing antibodies against HIV shows promise in children

explore

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medicare details structure of new drug price negotiation program

How to ethically and practically extend health care to all

Moonlake's readout produced a cash windfall. Risks remain

How to ethically and practically extend health care to all

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

It costs an awful lot of money to give away a kidney

As demand for Covid shots wanes, Moderna seeks its next success

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Wikipedia

FDA scientists endorse Pfizer/BioNTech Covid

When waiting feels immoral: Empathy in the emergency department

Heart disease in astronauts blamed on cosmic radiation

Sen. Bill Cassidy on how to lower drug prices

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

House panel to mark up pandemic

hotspot

hotspot

focus

explore